Effects of ivermectin on blood-feeding Phlebotomus papatasi, and the promastigote stage of Leishmania major.
Ivermectin (IVM) is a chemically modified macrocyclic lactone of Streptomyces avermitilis that acts as a potent neurotoxin against many nematodes and arthropods. Little is known of IVM's effect against either blood-feeding Phlebotomus sand flies, or the infective promastigote stage of Leishmania transmitted by these flies. We injected hamsters subcutaneously with two standard IVM treatments (200 and 400 μg/kg body weight) and allowed cohorts of Leishmania major-infected Phlebotomus papatasi to blood-feed on these animals at various posttreatment time points (4 h, 1, 2, 6, and 10 days). Infected and uninfected sand flies that bit treated and untreated hamsters served as controls. Serum levels of IVM in low- and high-dose-treated hamsters were determined at the five time points. Sand fly mortality following blood feeding was recorded at 24-h intervals and, in relation to IVM treatment, was time and dose dependent. Mortality was most rapid and greatest among infected flies that fed nearest to time of dosing. Mean survival of infected sand flies after feeding on untreated hamsters was 11.5 days, whereas that of infected sand flies that fed 4 h, 1 day, or 2 days posttreatment on high-dose-treated hamsters (400 μg/kg) was 1.6, 2.1, and 2.7 days, respectively. Infected and uninfected sand flies that blood fed 6 days following low-dose IVM treatment (200 μg/kg) still experienced significantly greater mortality (p < 0.02) than controls. Promastigotes dissected out of surviving flies that fed on IVM-treated hamsters showed typical motility and survival. Moreover, 21.7% of IVM-treated hamsters developed lesions after being fed upon by infected sand flies. L. major promastigotes appeared to be tolerant to ng/mL blood levels of IVM that caused significant mortality for up to 10 days posttreatment in blood-feeding P. papatasi.
Hanafi
Hanafi A
HA
Vector Biology Research Program, U.S. Naval Medical Research Unit No. 3, Cairo, Egypt. hanafi.hanafi.ctr.eg@med.navy.mil
Szumlas
Daniel E
DE
Fryauff
David J
DJ
El-Hossary
Shabaan S
SS
Singer
Gamal A
GA
Osman
Samir G
SG
Watany
Noha
N
Furman
Barry D
BD
Hoel
David F
DF
D000818:Animals; D006224:Cricetinae; D007303:Insect Vectors / Q000187:drug effects / Q000469:parasitology / Q000502:physiology; D007559:Ivermectin / Q000097:blood / Q000494:pharmacology*; D018320:Leishmania major / Q000187:drug effects* / Q000254:growth & development; D007896:Leishmaniasis / Q000517:prevention & control* / Q000635:transmission; D008018:Life Cycle Stages / Q000187:drug effects; D008647:Mesocricetus / Q000097:blood* / Q000469:parasitology; D010691:Phlebotomus / Q000187:drug effects* / Q000469:parasitology*
D007559:Ivermectin